Drug Discovery

27 Jul 2020
- Drug Discovery
- Research & Development
Moderna announces expansion of BARDA agreement to support larger phase 3 programme for Covid-19 vaccine

By PBR Staff Writer

Moderna, a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced a modification to its contract with the Biomedical Advanced Research and Development Authority (BARDA) for an additional commitment of up to $472 million to support late stage clinical development including the expanded Phase 3 study of the Company’s mRNA vaccine candidate (mRNA-1273) against Covid-19.
24 Jul 2020
Drug Discovery
Research & Development
Novartis announces phase III study of Jakavi in chronic graft-versus-host disease met primary and key secondary endpoints

By PBR Staff Writer

Novartis announced that the Phase III REACH3 study evaluating Jakavi® (ruxolitinib) in patients with steroid-refractory or steroid-dependent chronic graft-versus-host disease (GvHD) met its primary endpoint of superior overall response rate (ORR) at Week 24 versus best available therapy (BAT).
24 Jul 2020
Drug Discovery
Clinical Trials
7000RMS Services

By victoria.smith

Expert system services provide peace of mind and ensure that your analyzer is performing optimally to deliver process control.
22 Jul 2020
Drug Discovery
Research & Development
Roche, Jnana sign multi-target collaboration deal for small molecule drugs

By PBR Staff Writer

Jnana Therapeutics has signed a multi-target collaboration and license deal worth over $1bn with Roche for the discovery of small molecule drugs for the treatment of immune-mediated and neurological diseases.
22 Jul 2020
Drug Discovery
Research & Development
Gilead Sciences to buy 49.9% stake in Tizona Therapeutics for $300m

By PBR Staff Writer

Gilead Sciences has agreed to invest up to $300m to acquire a 49.9% equity stake in clinical-stage immunotherapy company Tizona Therapeutics.
21 Jul 2020
Drug Discovery
Research & Development
JW Therapeutics acquires Syracuse and license to Eureka’s solid tumour technology in China

By PBR Staff Writer

JW Therapeutics announced the acquisition of Syracuse Biopharma (Hong Kong) Limited, which includes the license for Eureka Therapeutics’ ARTEMIS antibody TCR and solid tumor technology for exclusive use in China and the ASEAN countries.
21 Jul 2020
Drug Discovery
Research & Development
GSK to acquire 10% stake in German biotech company CureVac

By PBR Staff Writer

British drugmaker GlaxoSmithKline (GSK) has agreed to invest up to €150m to acquire a 10% stake in German biotech company CureVac.
17 Jul 2020
Drug Discovery
Research & Development
Tonix announces collaboration to develop precision medicine techniques for Covid-19 vaccines and therapeutics

By PBR Staff Writer

Tonix Pharmaceuticals Holding, a clinical-stage biopharmaceutical company, announced it has entered into a research collaboration and option agreement with Columbia University focused on studying the immune responses to COVID-19 in healthy volunteers who have recovered from COVID-19 or were asymptomatic.
17 Jul 2020
Production & Sales
Drug Discovery
Marketing & Sales
Novartis to offer not-for-profit medicines to treat Covid-19 patients

By PBR Staff Writer

Swiss pharmaceutical firm Novartis has announced that its Sandoz division will provide a portfolio of 15 not-for-profit generic and over-the-counter (OTC) medicines to developing countries to treat the patients with Covid-19 symptoms.
16 Jul 2020
Drug Discovery
Research & Development
US university says common FDA-approved drug may effectively neutralise SARS-CoV-2 virus

By PBR Staff Writer

A common drug, already approved by the Food and Drug Administration (FDA), may also be a powerful tool in fighting COVID-19, according to research published this week in Antiviral Research.

Drug Discovery

Research & Development

Pfizer and Innovent Biologics sign $10.5bn cancer drug development deal

SK bioscience and VECOL partner on Colombia vaccine manufacturing initiative

Clinical Trials

Patient Enrollment

US FDA approves Avacta Group’s IND application for AVA6000

AM-Pharma enrols first patients in Covid-19 phase III trial

Regulation

Drug Filing

Viatris files applications in Japan for approval of Effexor to treat GAD

Scholar Rock submits application of SMA therapy to FDA

Production & Sales

Manufacturing

ENCell and Lucy Biotech forge alliance for mesenchymal stem cell therapy

Merck introduces single-use reactor to accelerate ADC manufacturing

Packaging & Supply Chain

Packaging

Gerresheimer at CPHI Frankfurt 2025

Gerresheimer

Suppliers

No data found

Drug Discovery

Moderna announces expansion of BARDA agreement to support larger phase 3 programme for Covid-19 vaccine

Novartis announces phase III study of Jakavi in chronic graft-versus-host disease met primary and key secondary endpoints

7000RMS Services

Roche, Jnana sign multi-target collaboration deal for small molecule drugs

Gilead Sciences to buy 49.9% stake in Tizona Therapeutics for $300m

JW Therapeutics acquires Syracuse and license to Eureka’s solid tumour technology in China

GSK to acquire 10% stake in German biotech company CureVac

Tonix announces collaboration to develop precision medicine techniques for Covid-19 vaccines and therapeutics

Novartis to offer not-for-profit medicines to treat Covid-19 patients

US university says common FDA-approved drug may effectively neutralise SARS-CoV-2 virus

Pharmaceutical Business review is using cookies

Research & Development

Patient Enrollment

Drug Filing

Manufacturing

Packaging

No data found